JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Home
Signaling Pathways

Signaling Pathways

A8513 Riluzole

Target: Voltage-gated Sodium (NaV) Channels|glutamate release

Summary: Sodium channel protein inhibitor

≥23.4 mg/mL
A8407 Dibucaine (Cinchocaine) HCl

Summary: Sodium channel inhibitor

≥11.9 mg/mL
B5594 TC-N 1752

Summary: human NaV1.7 channels blocker
B5765 PF 04885614

Summary: NaV1.8 inhibitor

<28.53 mg/mL
B5802 ICA 121431

Summary: human NaV1.3 and NaV1.1 channels inhibitor

Soluble in DMSO
B4798 Procainamide HCl

Target: DNA Methyltransferases

Summary: sodium channel blocker

≥13.65 mg/mL
B5850 GS967

Summary: inhibitor of cardiac late sodium current

insoluble in H2O; ≥13.35 mg/mL
B5894 Rostafuroxin (PST 2238)

Summary: Na+/K+ ATPase modulator

insoluble in H2O; insoluble in EtOH; ≥12.05 mg/mL
B5895 CARIPORIDE

Target: NHE

Summary: Potent NHE inhibitor

insoluble in H2O; ≥12.05 mg/mL
B5927 GSK1014802(CNV1014802)

Summary: Novel sodium channel blocker

Soluble in DMSO